H.C. Wainwright raised the firm’s price target on Fortress Biotech (FBIO) to $26 from $24 and keeps a Buy rating on the shares following the Q3 report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FBIO:
- Fortress Biotech’s Q3 2024 Earnings and FDA Milestone
- Fortress Biotech Inc (FBIO) Q3 Earnings Cheat Sheet
- Fortress Biotech files to sell 6.19M shares of common stock for holders
- Biotech Alert: Searches spiking for these stocks today
- Fortress Biotech to sell 3.9M shares at $1.65 in registered direct offering